Rapid communication
IL-1 or TNF receptor gene deletion delays onset of encephalopathy and attenuates brain edema in experimental acute liver failure

https://doi.org/10.1016/j.neuint.2009.11.010Get rights and content

Abstract

Previous reports suggested that brain-derived proinflammatory cytokines are involved in the pathogenesis of hepatic encephalopathy (HE) and brain edema in acute liver failure (ALF). To further address this issue, expression of interleukin-1beta (IL-1β), tumor necrosis factor-alpha (TNF-α) and interferon-gamma (IFN-γ) mRNAs were measured in the brains of mice with acute liver failure resulting from exposure to azoxymethane. In addition, time to severe encephalopathy (coma) was assessed in mice lacking genes coding for interferon-gamma, the tumor necrosis factor receptor-1 or the interleukin-1 type 1 receptor. Interleukin-1beta, tumor necrosis factor-alpha and interferon-gamma expression were quantified using RT-PCR. Significant increases in interleukin-1beta and tumor necrosis factor-alpha mRNA were observed in the frontal cortex of azoxymethane-treated wild-type mice at coma stages of encephalopathy. Interferon-gamma, however, could not be detected in the brains of these animals. Onset of severe encephalopathy (coma) and brain edema in ALF mice were significantly delayed in interleukin-1 type 1 receptor or tumor necrosis factor receptor-1 knockout mice. Deletion of the interferon-gamma gene, on the other hand, had no significative effect on the neurological status or brain water content of acute liver failure mice. These results demonstrate that toxic liver injury resulting from exposure to azoxymethane is associated with selective induction of proinflammatory cytokines in the brain and that deletion of tumor necrosis factor receptor-1 or interlukin-1 type 1 receptor delays the onset of coma and brain edema in this model of acute liver failure. These findings further support a role for selective brain-derived cytokines in the pathogenesis of the cerebral complications in acute liver failure and suggest that anti-inflammatory strategies could be beneficial in their prevention.

Section snippets

Acknowledgement

This study was supported by a grant from the Canadian Institutes for Health Research. C.B. is a recipient of a fellowship from the Canadian Association for the Study of the Liver (CASL)/Astellas Pharma Canada.

References (14)

  • J.J. Alexander et al.

    TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1

    Neurochem. Int.

    (2008)
  • M. Bélanger et al.

    Neurobiological characterization of an azoxymethane mouse model of acute liver failure

    Neurochem. Int.

    (2006)
  • R.F. Butterworth

    Role of circulating neurotoxins in the pathogenesis of hepatic encephalopathy: potential for improvement following their removal by liver assist devices

    Liver Int.

    (2003)
  • L. Fransen et al.

    Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression

    Nucleic Acids Res.

    (1985)
  • P.W. Gray et al.

    Two interleukin 1 genes in the mouse: cloning and expression of the cDNA for murine interleukin 1 beta

    J. Immunol.

    (1986)
  • P.W. Gray et al.

    Cloning and expression of murine immune interferon cDNA

    Proc. Natl. Acad. Sci. U.S.A.

    (1983)
  • R. Jalan et al.

    Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure

    Transplantation

    (2003)
There are more references available in the full text version of this article.

Cited by (87)

  • The contributions of bacteria metabolites to the development of hepatic encephalopathy

    2023, Liver Research
    Citation Excerpt :

    Chronic hyperammonemia is sufficient to induce astrocyte and microglial activation, resulting in brain-derived proinflammatory tumor necrosis factor-alpha (TNF-α), interleukin (IL)-6, and IL-1β (Fig. 1).24–27 In an azoxymethane (AOM) induced HE mouse model, TNF-α receptor knockout (KO) mice had decreased brain swelling as opposed to the wild-type mice, further showing the impact of TNF-α on brain inflammation.28 This inflammatory state leads to neuronal death in vitro and in vivo.29

  • Standard-Volume Plasma Exchange Improves Outcomes in Patients With Acute Liver Failure: A Randomized Controlled Trial

    2022, Clinical Gastroenterology and Hepatology
    Citation Excerpt :

    Our study observed a significant difference in proinflammatory cytokines (IL-1α, IL-1β IL-6, IL-17 and HMGB1 between the SVPE and SMT groups. Prior studies performed in humans and animal models of ALF have demonstrated these cytokines’ role in causing brain edema.2,3,7 We also observed a significant increase in the levels of IL-1RA with PE therapy.

View all citing articles on Scopus
View full text